Product Images Riluzole

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Riluzole NDC 62756-538 by Sun Pharmaceutical Industries, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

label - label

label - label

This is a description for Riluzole Tablets, USP distributed by Sun Pharmaceutical Industries, Inc. The tablets contain 50mg of riluzole USP and are sold in a bottle of 30 tablets. The recommended dosage is one tablet every 12 hours. The tablets are manufactured by Sun Pharmaceutical Industries Ltd. in Halol-Baroda Highway, Gujarat, India. The tablets should be stored at a temperature between 20° and 25°C (68° and 77°F) and protected from bright light. This medication should be kept out of reach of children.*

spl-riluzole-figure1 - spl riluzole figure1

spl-riluzole-figure1 - spl riluzole figure1

This text presents data on survival probability with a visualization of Kaplan-Meier Survival Curves for Riluzole at 50 mg taken twice daily compared with a placebo group with a sample size of 77 and 78 respectively.*

spl-riluzole-figure2 - spl riluzole figure2

spl-riluzole-figure2 - spl riluzole figure2

This appears to be a graph showing Kaplan-Meier Survival Curves for Riluzole 50mg twice daily (N=236) versus Placebo (N=242). The text indicates a survival probability of 0.7 and there are numbers and symbols that are not legible. Without further context, it is difficult to provide a more detailed description.*

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.